June 2018 Briefing - Internal Medicine
Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Urology
Here are what the editors at HealthDay consider to be the most important developments in Urology for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Gastroenterology
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Cardiology
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - HIV & amp; AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV& AIDS for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Radiology
Here are what the editors at HealthDay consider to be the most important developments in Radiology for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Family Practice
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Cosmetic Surgery
Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Pathology
Here are what the editors at HealthDay consider to be the most important developments in Pathology for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Dermatology
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Psychiatry
Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Otolaryngology
Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Geriatrics
Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Pain Management
Here are what the editors at HealthDay consider to be the most important developments in Pain Management for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Hematology & amp; Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology& Oncology for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Nursing
Here are what the editors at HealthDay consider to be the most important developments in Nursing for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Ophthalmology
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

June 2018 Briefing - Diabetes & amp; Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes& Endocrinology for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets approval to manufacture pain reliever Ibuprofen
"The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture Ibuprofen capsules OTC, 200 mg," Pharma said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 2, 2018 Category: Pharmaceuticals Source Type: news

Natco Pharma launches Hepatitis C drug in India
Natco Pharma launched fixed dose combination of Sofosbuvir-Daclatasvir tablets for the treatment of Hepatitis C under the brand name Hepcinat Plus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 2, 2018 Category: Pharmaceuticals Source Type: news

The Importance Of The Healthcare Sector To The Sustainable Development Goals
The healthcare sector, particularly its biotech and pharmaceutical industries, has a very important role to play in achieving the Sustainable Development Goals (SDGs). This conclusion is based on a mapping of its material environmental, social, and governance issues to the targets of the SDGs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 1, 2018 Category: Pharmaceuticals Authors: Dr. Bob Eccles, Contributor Source Type: news

Oaksterdam Offers Hands-On Horticulture Lessons To Cannabis Students
Students from around the world come to Oakland to learn about growing cannabis (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 1, 2018 Category: Pharmaceuticals Authors: Julie Weed, Contributor Source Type: news

Where Do Older Americans Die?
Increasingly older Americans are dying at home rather than in a hospital. But many still spend time in intensive care units or shuttle from one care setting to another as they near the end of life (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 1, 2018 Category: Pharmaceuticals Authors: Howard Gleckman, Contributor Source Type: news

Trump's Medicaid Work Rules Were Adding To Costs Even Before A Judge Blocked Them
The Trump administration ’s effort to require Medicaid patients to work has already been adding to costs from a new layer of administrative bureaucracy that began even before a federal judge ruled against them. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 1, 2018 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:WCG NYSE:UNH NYSE:CNC NYSE:CI NYSE:AET Source Type: news

Pediatrician Bob Sears Punished For Questionable Vaccine Exemption
" Dr Bob " Sears, known for promoting a non-evidence-based vaccination schedule contrary to the CDC schedule, has been sanctioned by California's Medical Board. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 1, 2018 Category: Pharmaceuticals Authors: Tara Haelle, Contributor Source Type: news

Pediatrician Bob Sears' Punished For Questionable Vaccine Exemption
" Dr Bob " Sears, known for promoting a non-evidence-based vaccination schedule contrary to the CDC schedule, has been sanctioned by California's Medical Board. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 1, 2018 Category: Pharmaceuticals Authors: Tara Haelle, Contributor Source Type: news

Pediatrician Bob Sears' License Temporarily Revoked After Questionable Vaccine Exemption
" Dr Bob " Sears, known for promoting a non-evidence-based vaccination schedule contrary to the CDC schedule, has been sanctioned by California's Medical Board. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 1, 2018 Category: Pharmaceuticals Authors: Tara Haelle, Contributor Source Type: news

Chinese investment into US biotech start-ups soars
Growth in key strategic sector flies below radar of regulators in Washington (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 1, 2018 Category: Pharmaceuticals Source Type: news

Top 5 Stocks Under $10
We are re-introducing an old concept of buying stocks below a $10 stock price. CressCap has to identified five stocks under $10 that possess the above core fundamental metrics which we desire. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 1, 2018 Category: Pharmaceuticals Authors: Steven Cress, Contributor Source Type: news

What ’s Columbus, Ohio without the support of blood donors?
C —lum—us, —hi— just doesn’t cut it. The missing letters B and O — along with A — represent our blood types, and we may not realize how vital they are until they’re gone. When too few people donate blood, A’s, B’s and O’s go missing from hospital shelves, putting lives in danger . The availability of blood is critical, as someone needs it in an emergency every two seconds in the U.S. Donating is incredibly impactful — one donation saves up to three lives — and simple. From… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 1, 2018 Category: Pharmaceuticals Authors: Nationwide Source Type: news

It ’s easy to host a blood drive at your business
Every two seconds — that’s how often someone in the U.S. needs blood. And, according to the American Red Cross – Ohio Buckeye Region, approximately 500 donations are needed each day in Central Ohio. Blood is needed for routine surgeries, chemotherapy, the treatment of chronic illnesses like sickle cell disease and in saving lives after a traumatic event— one car accident victim can require as many as 100 pints of blood. But despite advancements made in modern medicine, we can’t manufacture… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 1, 2018 Category: Pharmaceuticals Authors: Nationwide Source Type: news

What your employees don't know about their health plans can cost your business
When your employees don ’t understand their health plans, it can cost them — and you. According to a recent survey, 96 percent of Americans said they knew the meaning of four common health insurance terms that relate to out-of-pocket (OOP) costs — deductible, coinsurance, copay, and out-of-pocket-maximum. But of th ose surveyed, only 4 percent actually knew the correct meaning of all four terms. And almost 1/3 of consumers don’t know what their health plan’s deductible and OOP maximum benefits… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 1, 2018 Category: Pharmaceuticals Authors: Highmark Employer Resources Team Source Type: news

A hearty menu of health benefits attract, and keep, the best employees
The job market is increasingly competitive for employers. In fact, 86 percent of recruiters say the labor market is “candidate-driven.” That compares to just 56 percent in 2012. And 62 percent of employers believe talent demands are driving the job market today. One way to stand out and attract the best talent is to offer a diverse menu of healt h benefits. Because workers of different ages will want different things from their health plan. So finding the right mix of benefits can help… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 1, 2018 Category: Pharmaceuticals Authors: Highmark Employer Resources Team Source Type: news

Dr Reddy's recalls 2.36 lakh bottles of cholesterol lowering tablets from US
A class III recall is initiated in a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 1, 2018 Category: Pharmaceuticals Source Type: news

Disruptive Innovations in Clinical Trials Event (DPharm) Announces...
DPharm 2018 is the event reporting on the latest in innovative projects,...(PRWeb July 01, 2018)Read the full story at https://www.prweb.com/releases/2018/07/prweb15601304.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 1, 2018 Category: Pharmaceuticals Source Type: news

1-800-PetMeds ® Teams up with Bayer in the Happy, Healthy Summer...
America’s Largest Pet Pharmacy® and Bayer are turning up the heat this summer with this pawsome giveaway! In July, the Healthy, Happy Summer Sweepstakes will give lucky entrants a chance to win a...(PRWeb July 01, 2018)Read the full story at https://www.prweb.com/releases/2018/06/prweb15598894.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 1, 2018 Category: Pharmaceuticals Source Type: news

Amazon to become your Big Pharma drug dealer: Purchases online pharmacy for nearly $1 billion
(Natural News) Amazon may have paid nearly $1 billion for the online pharmacy, PillPack, but what is the real cost of this acquisition going to be for consumers? In the aftermath of Amazon’s lofty purchase, three of the largest pharmacies in the U.S. (Walgreen’s, CVS and Rite Aid) lost a collective $11 billion in market value in... (Source: NaturalNews.com)
Source: NaturalNews.com - June 30, 2018 Category: Consumer Health News Source Type: news

Top Tips For Avoiding A Hot Summer Hangover
It ’s finally summer. Here come the parties, festivals, extended weekends and long, hot days, with cool beverages. But the combination of alcohol, sun and heat can take a nasty toll on you the day – or two – after drinking. So here are some tips for preventing and recovering from a nasty hangover . (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 30, 2018 Category: Pharmaceuticals Authors: Nicole Fisher, Contributor Source Type: news

Many Fast-Growing U.S. Exports To Collide With Trump's Tariff Battle
U.S. exports are enjoying their fastest growth in seven years, as Trump pushes ahead with plans to levy tariffs on imports from largely European and Asian countries, leading to retaliation. With apologies to Dickens, this is either best of times or the worst of times for this. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 30, 2018 Category: Pharmaceuticals Authors: Ken Roberts, Contributor Source Type: news

I Went To A Retreat About Radical Listening And This Is What I Learned
Four days of intense radical listening transformed the way I interact with others. Learn why we ALL need to incorporate this key skill. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 30, 2018 Category: Pharmaceuticals Authors: Lipi Roy, Contributor Source Type: news

Lionel Messi: How Fair Are People About His World Cup Body Language?
What are the supposed body language signs of disinterest and defeat? Do these signs apply in this case? It's Messi. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 30, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Study Shows How Bad People Are At Washing Their Hands
These are the things that people are doing that are both gross and disgusting. They are gross-tusting. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 30, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

John Sculley Weighs In On Amazon, Health M & A And The Future Of PBMs
Amazon is buying pharma start-up PillPack for around $1 Billion. Buffet, Bezos and Dimon (Berkshire-Amazon-JPMorgan Chase) created an entity that will be headed by Dr. Atul Gawande. So John Sculley was the perfect person to ask about the last few days prognosticate on the health-tech M&A space. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 30, 2018 Category: Pharmaceuticals Authors: Nicole Fisher, Contributor Tags: NYSE:CVS NYSE:HUM NASDAQ:AMZN NYSE:WMT NASDAQ:AAPL Source Type: news

Do You Have Excessive Armpit Sweating? FDA Approves New Drug From Dermira
The U.S. Food and Drug Administration (FDA) has just approved, Qbrexza, a new treatment for the condition otherwise known as primary axillary hyperhidrosis. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 30, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Do You Have Excessive Armpit Sweating? FDA Approves New Drug From Demira
The U.S. Food and Drug Administration (FDA) has just approved, Qbrexza, a new treatment for the condition otherwise known as primary axillary hyperhidrosis. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 30, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Monthly News Roundup - June 2018
First Cannabis-Based Drug Epidiolex Approved for Childhood Seizures In June, the U.S. Food and Drug Administration (FDA) approved GW Pharmaceuticals'Epidiolex (cannabidiol) [CBD], an oral solution for patients two years and older to treat... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 30, 2018 Category: Pharmaceuticals Source Type: news

Kelsey-Seybold to open clinic in Baytown
Locally based Kelsey-Seybold Clinic will open its 20th Houston-area clinic next year. The new $2.5 million primary care clinic will be at 6340 Garth Road in Baytown, according to a press release. Less than one mile south of Interstate 10, the new location is within the Baytown Shops retail center anchored by an H-E-B grocery store that opened in December.  The 11,000-square-foot clinic was designed by Powers Brown Architecture, but Kelsey-Seybold has not selected a general contractor yet. The… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 29, 2018 Category: Pharmaceuticals Authors: Olivia Pulsinelli Source Type: news